{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T09:31:57Z","timestamp":1649151117603},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["transplantation-proceedings.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.transproceed.2014.09.177","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T18:20:01Z","timestamp":1416594001000},"page":"3100-3103","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hepatitis C Virus Recurrence After Liver Transplantation: How to Treat and When"],"prefix":"10.1016","volume":"46","author":[{"given":"V.","family":"Aguilera","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2014.09.177_bib1","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/j.lts.2003.09.018","article-title":"Evolution of liver transplantion in Europe: report of the European Liver Transplant Registry","volume":"9","author":"Kim","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2014.09.177_bib2","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0168-8278(00)80231-7","article-title":"HCV-related fibrosis progression following liver transplantation:increase in recent years","volume":"32","author":"Berenguer","year":"2000","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2014.09.177_bib3","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/lt.500040401","article-title":"Cholestatic hepatitis C in liver allografts","volume":"4","author":"Taga","year":"1998","journal-title":"Liver Transpl Surg"},{"key":"10.1016\/j.transproceed.2014.09.177_bib4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1002\/lt.22461","article-title":"Recipient-donor race mismatch for African-American liver transplant patients with chronic hepatitis C","volume":"18","author":"Saxena","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2014.09.177_bib5","first-page":"716","article-title":"Outcome of HCV\/HIV-coinfected liver transplant recipients: a prospective and multicenter cohort study","volume":"18","author":"Miro","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2014.09.177_bib6","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1053\/jlts.2002.32282","article-title":"Impact of cytomegalovirus infection, year of transplantation and donor age on outcomes after liver transplantation for hepatitis C","volume":"8","author":"Burak","year":"2002","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2014.09.177_bib7","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.jhep.2010.10.037","article-title":"Impact of donor and recipient ILB28 rs12979860 genotypes on hepatitis C virus liver graft reinfection","volume":"55","author":"Lange","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2014.09.177_bib8","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jhep.2006.10.017","article-title":"Sustained virological response to antiviral therapy reduces mortality in HCV reinfection after transplantation","volume":"46","author":"Picciotto","year":"2007","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2014.09.177_bib9","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1111\/j.1600-6143.2007.02126.x","article-title":"Clinical benefits of antiviral therapy in patients with recurrent hepatitis C following liver transplantation","volume":"8","author":"Berenguer","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2014.09.177_bib10","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1016\/S0041-1345(00)02508-2","article-title":"Prevention of recurrent hepatitis C after liver transplantation with early interferon and ribavirin","volume":"33","author":"Mazzafeerro","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2014.09.177_bib11","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2005.02.015","article-title":"Combined treatment (alpha 2-b) and ribavirin in the acute phase of hepatitis C virus recurrence after liver transplantation","volume":"43","author":"Castells","year":"2005","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2014.09.177_bib12","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/lt.21707","article-title":"Worse recent efficacy of antiviral therapy in liver transplant recipients with recurrent hepatitis C: impact of donor age and baseline cirrhosis","volume":"15","author":"Berenguer","year":"2009","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2014.09.177_bib13","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/lt.21635","article-title":"Hepatitis C virus therapy in liver transplant recipients: response, predictors, effect of fibrosis progression and importance of the initial stage of fibrosis","volume":"14","author":"Roche","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2014.09.177_bib14","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/j.1600-6143.2011.03491.x","article-title":"Donor and recipient IL28B polymorphisms in HCV-infected patients undergoing antiviral therapy before and after liver transplantation","volume":"11","author":"Coto-Llerena","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2014.09.177_bib15","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jhep.2011.12.031","article-title":"Comparison of two noncontemporaneous HCV-liver transplant cohorts: strategies to improve the efficacy of antiviral therapy","volume":"56","author":"Berenguer","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2014.09.177_bib16","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1053\/j.gastro.2012.01.030","article-title":"Risk for immune-mediated graft dysfunction in liver transplant recipients with recurrent HCV infection treated with pegylated interferon","volume":"142","author":"Levitsky","year":"2012","journal-title":"Gastroenterology"},{"issue":"Suppl","key":"10.1016\/j.transproceed.2014.09.177_bib17","first-page":"9","article-title":"Efficacy and safety of protease inhibitors for hepatitis C recurrence after liver transplantation; a first multicentric experience","volume":"56","author":"Coilly","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2014.09.177_bib18","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1002\/lt.23542","article-title":"Short report: telaprevir-based triple therapy in liver transplanted HCV patients: a 112 week pilot study providing safety and efficacy","volume":"18","author":"Werner","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2014.09.177_bib19","doi-asserted-by":"crossref","first-page":"S572","DOI":"10.1016\/S0168-8278(13)61421-X","article-title":"End of treatment response after protease inhibitor (PI)\u2013based therapy for hepatitis C recurrence after liver transplantation: a multicentric European experience","volume":"58","author":"Coilly","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2014.09.177_bib20","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/S0168-8278(13)60025-2","article-title":"A\u00a0multicenter study of protease inhibitor\u2013triple therapy in HCV-infected liver transplant recipients: reported from the CRUSH-C group","volume":"58","author":"Verna","year":"2013","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2014.09.177_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jhep.2013.08.018","article-title":"Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation. A multicenter experience","volume":"60","author":"Coilly","year":"2014","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2014.09.177_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1002\/hep.24443","article-title":"Effect of telaprevir on the pharmacokinetics of cyclosporine and tacrolimus","volume":"54","author":"Garg","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2014.09.177_bib23","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1002\/hep.25831","article-title":"Pharmacokinetic interaction between the hepatitis C virus protease inhibitor boceprevir and cyclosporine and tacrolimus in healthy volunteers","volume":"56","author":"Hulskotte","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2014.09.177_bib24","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1128\/AAC.01151-12","article-title":"Practical management of boceprevir and immunosuppressive therapy in liver transplant recipients with hepatitis C virus recurrence","volume":"56","author":"Coilly","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.transproceed.2014.09.177_bib25","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1002\/lt.23669","article-title":"Multicenter experience using telaprevir or boceprevir with peg-interferon and ribavirin treat hepatitis C genotype 1 after liver transplantation","volume":"19","author":"Pupapong","year":"2013","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2014.09.177_bib26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1002\/lt.23482","article-title":"Case report of successful peginterferon, ribavirin and daclatasvir therapy for recurrent cholestatic hepatitis C after liver retransplantation","volume":"18","author":"Fontana","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2014.09.177_bib27","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1111\/ajt.12209","article-title":"Sofosbuvir and daclatasvir combination therapy in a liver transplant recipient with severe recurrent cholestatic hepatitis C","volume":"13","author":"Fontana","year":"2013","journal-title":"Am J Transplant"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134514010276?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134514010276?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T14:55:43Z","timestamp":1538060143000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134514010276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S0041134514010276"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.09.177","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatitis C Virus Recurrence After Liver Transplantation: How to Treat and When","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2014.09.177","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}